A therapeutic version still undergoing trials would carry a larger dose of radioactive material, thereby taking radiation therapy direct to the cancerous cells. A stage-III trial of that product, which is estimated to be potentially 30 times more profitable than the diagnostic tool, is currently recruiting patients.
if Illuccix is going to bring in .... lets just say a billion dollars
i like the sound of "30 times more profitable"
not going to bother with numbers on that - it's just upside which will take care of itself
it appears this Nasdaq listing is putting a spotlight on TLX . maybe the rest of the world will see what we can see ?
thanks spnc
News: TLX Telix Pharmaceuticals Aims Up To $4.17 Bln Valuation In US IPO, page-62
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.90 |
Change
-0.010(0.04%) |
Mkt cap ! $7.664B | |||
| Open | High | Low | Value | Volume |
| $23.00 | $23.19 | $22.40 | $16.31M | 715.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3391 | $22.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.93 | 2866 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |